Canadian Ticagrelor Survey

Study identifier:D5130L00009

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Effectiveness of risk minimisation interventions for ticagrelor in Canada

Medical condition

Acute Coronary Syndrome

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

244

Study type

Observational

Age

18 Years - 85 Years

Date

Study Start Date: 01 Nov 2012
Primary Completion Date: 01 Dec 2014
Study Completion Date: 01 Dec 2014

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2015 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria